Novavax | NVAX - Equity Capital And Reserves

Stock Price
8.45
Daily Change
-0.50 -5.59%
Monthly
-16.42%
Yearly
20.71%
Q1 Forecast
8.20

Novavax reported $-127.75M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Adma Biologics USD 477.32M 46.13M Dec/2025
Agenus USD -271.11M 3.03M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
BioCryst Pharmaceuticals USD -119.15M 268.74M Dec/2025
Cassava Sciences USD 74.4M 7.16M Dec/2025
Geron USD 225.87M 22.83M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
MannKind USD -51.02M 6.47M Dec/2025
Merck USD 51.85B 2.79B Sep/2025
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Moderna USD 8.65B 680M Dec/2025
Novartis USD 46.13B 1.8B Dec/2025
Novavax USD -127.75M 28.92M Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Sarepta Therapeutics USD 1.14B 179.5M Dec/2025
TG Therapeutics USD 648.02M 40.8M Dec/2025